Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Then, weekly for a few more weeks
Retatrutide is an investigational triple agonist peptide that targets three key metabolic receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Sustainable weight loss occurs when medication supports behavior change, metabolic improvement, and long-term habits
People with large employer coverage pay an average of nearly $70 per month in out-of-pocket costs for semaglutide when these drugs are covered by their health plan, though this is a small share of the total cost of the drug
These medications have sparked tremendous interest, yet its crucial to understand both their benefits and limitations before adding them to your own health journey
That matters for patients testing the waters who want to minimize their initial financial commitment
US$ 28.31
US$ 27.12
US$ 21.44
